Cefinate OLB
Cefinate OLB Products are primarily used for
Bacterial infections
About Cefinate OLB Products
Uses of Cefinate OLB Products
Cefixime+Ofloxacin+Lactobacillus is used in the treatment of bacterial infections.
Cefinate OLB Products side effects
Common
Side Effects of Cefinate OLB are Nausea, Vomiting, Diarrhea, Stomach pain, Indigestion, Flatulence.
How Cefinate OLB Products work
Cefixime + Ofloxacin + Lactobacillus is a combination of three medicines: Cefixime + Ofloxacin + Lactobacillus1, Cefixime + Ofloxacin + Lactobacillus2, and Cefixime + Ofloxacin + Lactobacillus3. Cefixime + Ofloxacin + Lactobacillus1 works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Cefixime + Ofloxacin + Lactobacillus2 works by preventing the bacteria from reproducing and repairing themselves. Together, they eradicate your infection effectively. Cefixime + Ofloxacin + Lactobacillus3 is a live micro-organism which restores the balance of good bacteria in the intestine that may get upset with antibiotic use or due to intestinal infections.
Patient Concerns about Cefinate OLB Products
Frequently asked questions about Cefinate OLB Products
Frequently asked questions about Cefinate OLB Products
Q. Can I stop taking Cefinate OLB Tablet when I feel better?
No, do not stop taking Cefinate OLB Tablet and complete the full course of treatment even if you feel better. Your symptoms may improve before the infection is completely cured.
Q. What if I miss my dose?
Take Cefinate OLB Tablet as soon as you remember it. However, do not take it if it's almost time for your next dose. Also, do not take an extra dose to make up for your missed dose.
Q. What if I don't get better after using Cefinate OLB Tablet?
Inform your doctor if you don't feel better after finishing the full course of treatment. Also, inform him if your symptoms are getting worse while using this medicine.
Products for Cefinate OLB
Cefinate OLB Tablet
strip of 10 tablets
MRP
₹170
Not Available